The main objective of a clinical research study is to answer questions about the safety and effectiveness of potential new medications. These studies must be completed before a new treatment can be offered to the public.
If you’re at risk for Alzheimer’s Disease, you may be eligible for a clinical research study. Your brain may show signs of Alzheimer’s disease before you ever notice any changes in your memory or ability to think clearly.
This study involves people who have normal memory, thinking, mood and behavior patterns. Participants are randomly assigned to one of two groups. They receive either the investigational drug or a placebo. Those who receive placebo may have the option to receive the investigational drug at a later time.
Bradenton Research Center
Since 1992, Bradenton Research Center has completed over 150 clinical research studies. The diseases we’ve studied include Alzheimer’s Disease, Parkinson’s Disease, Influenza, Migraines, Neuropathic Pain, Gout, Hypertension, Stroke, Type 2 Diabetes, Diabetic Neuropathy, Epilepsy, COVID-19, and many others.
Patients enrolled in our studies are closely monitored by our research physicians and coordinators. All study-related care and medication is provided to our patients at no cost.
It is fulfilling to see the significant progress in the treatments of the diseases we’ve studied. We’re currently engaged in more than a dozen studies that will continue to move us closer to finding these better treatments and cures.